919508-08-0Relevant academic research and scientific papers
Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
-
, (2010/03/02)
The present invention relates to a pharmaceutical formulation comprising 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(cis-2,6-dimethylpiperidin-1-yl)-4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide as racemate or (S)-enantiomer or mixtures thereof in a sol
Substituted pyrazoline for preventing weight gain
-
Page/Page column 163, (2008/12/07)
The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, known to produce weight-gain as a side effect, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.
Active substance combination for the treatment of diabetes
-
Page/Page column 164, (2008/12/07)
The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, used to treat diabetes, a medicament comprising said active substance combination, a pharmaceutical formulation
